O'Shaughnessy Asset Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.25M Sell
11,730
-4,320
-27% -$523K 0.01% 1138
2026
Q1
$2.62M Sell
16,050
-5,879
-27% -$904K 0.01% 756
2025
Q4
$3.82M Buy
21,929
+8,703
+66% +$1.59M 0.02% 597
2025
Q3
$1.9M Buy
13,226
+1,886
+17% +$231K 0.01% 847
2025
Q2
$1.14M Buy
11,340
+1,510
+15% +$115K 0.01% 1008
2025
Q1
$750K Buy
9,830
+1,155
+13% +$88.4K 0.01% 1124
2024
Q4
$599K Sell
8,675
-1,562
-15% -$112K 0.01% 1204
2024
Q3
$769K Buy
10,237
+7,203
+237% +$532K 0.01% 1029
2024
Q2
$203K Buy
+3,034
New +$118K ﹤0.01% 1537
2021
Q4
– Sell
-2,995
Closed -$83K – 1831
2021
Q3
$83K Hold
2,995
– – ﹤0.01% 1444
2021
Q2
$85K Sell
2,995
-14
-0.5% -$416 ﹤0.01% 1364
2021
Q1
$102K Buy
3,009
+14
+0.5% +$535 ﹤0.01% 1187
2020
Q4
$100K Buy
+2,995
New +$109K ﹤0.01% 1067

Other funds holding INSM

O'Shaughnessy Asset Management's INSM Position: Q2 2026 in Review

O'Shaughnessy Asset Management reduced its Insmed (INSM) stake by 27% in Q2 2026, selling an estimated $523K and leaving 11,730 shares worth $1.25M. The position accounts for 0.01% of the portfolio, ranked #1138.

O'Shaughnessy Asset Management first reported a position in INSM in Q4 2020 and has held it in 13 quarters since. The position peaked at $3.82M in Q4 2025. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • O'Shaughnessy Asset Management held 11,730 shares of Insmed worth $1.25M as of Q2 2026.
  • O'Shaughnessy Asset Management sold 4,320 Insmed shares in Q2 2026, an estimated $523K.
  • Insmed made up 0.01% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #1138 holding.
  • O'Shaughnessy Asset Management first reported a position in Insmed in Q4 2020 and has held it in 13 quarters since.
  • O'Shaughnessy Asset Management's Insmed position peaked at $3.82M in Q4 2025.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.